Statistics for The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis
Total visits
| views | |
|---|---|
| The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis | 52 |
Total visits per month
| views | |
|---|---|
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
File Visits
| views | |
|---|---|
| The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration_protocol for a systematic review and meta-analysis.pdf | 35 |
Top country views
| views | |
|---|---|
| United States | 15 |
| Portugal | 10 |
| India | 8 |
| China | 6 |
| Brazil | 4 |
| Singapore | 2 |
| Australia | 1 |
| Iraq | 1 |
| South Korea | 1 |
| Mongolia | 1 |
| Mexico | 1 |
| Romania | 1 |
Top city views
| views | |
|---|---|
| Kolkata | 2 |